-+ 0.00%
-+ 0.00%
-+ 0.00%

SKYE BIOSCIENCE- TO FUND ARECOR'S DEVELOPMENT ACTIVITIES WITH OPTION TO LICENSE RIGHTS TO NEW PROPRIETARY FORMULATION OF NIMACIMAB

Reuters·05/19/2025 09:00:49

Please log in to view news